Abstract
A total of 25 targeted hydrogen sulfide donor–pentacyclic triterpene hybrids were designed, synthesized and evaluated on the basis of inspiring reports about hydrogen sulfide donor molecules and oleanolic acid derivatives on anti-tumor activity. The results revealed that only some hybrids (10a, 10b, 12a, 12b, 13a, and 15b) showed moderate anti-proliferation activity against K562 cell line. It indicated that oleanane-type, (R)-lipoic acid and TBZ groups were much more favorable to the anti-proliferation activity. Furthermore, C-3 OH was more beneficial than C-28/29 COOH in the oleanane-type to the antitumor activity of the batch of (R)-lipoic acid derivatives. And among them, only compound 13a exhibited moderate anti-proliferation activity against both K562 and K562/ADR cell lines, while it exhibited no anti-proliferation activity against BEL-7402 and L-O2 cell lines. Therefore, it suggested that it was not suitable for hybridization of hydrogen sulfide donors attached to oleanolic acid, ursolic acid and glycyrrhetinic acid in the field of anti-tumor.
Similar content being viewed by others
References
Bazhanov N, Ansar M, Ivanciuc T, Garofalo RP, Casola A (2017) Hydrogen sulfide: a novel player in airway development, pathophysiology of respiratory diseases and antiviral defenses. Am J Respir Cell Mol Biol 57(4):403–410
Bharath S, Cochran BC, Hsu M, Liu J, Ames BN, Andersen JK (2002) Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 Cells: implications for parkinson’s disease therapy. Neurotoxicology 23(4):479–486
Bhragual DD, Kumar N, Garg VK, Sharma PK (2010) Review on plants having hepatoprotective activity. J Pharm Res 3(9):2077–2082
Caliendo G, Cirino G, Santagada V, Wallace JL (2010) Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals. J Med Chem 53(17):6275–6286
Chattopadhyay M, Kodela R, Nath N, Barsegian A, Boring D, Kashfi K (2012a) Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo. Biochem Pharmacol 83(6):723–732
Chattopadhyay M, Kodela R, Nath N, Dastagirzada YM, Velázquez-Martínez CA, Boring D, Kashfi K (2012b) Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect. Biochem Pharmacol 83(6):715–722
Chattopadhyay M, Kodela R, Olson KR, Kashfi K (2012c) NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model. Biochem Bioph Res Commun 419(3):523–528
Chen WL, Niu YY, Jiang WZ, Tang HL, Zhang C, Xia QM, Tang XQ (2015) Neuroprotective effects of hydrogen sulfide and the underlying signaling pathways. Rev Neurosci 26(2):129–142
Cheng KG, Su CH, Huang JY, Liu J, Zheng YT, Chen ZF (2016a) Conjugation of uridine with oleanolic acid derivatives as potential antitumor agents. Chem Biol Drug Des 88(3):329–340
Cheng KG, Su CH, Huang JY, Wang HS, Liu J, Zheng YT, Chen ZF (2016b) Synthesis and cytotoxic evaluation of several oleanolic acid–uracil/thymine conjugates. MedChemComm 7(5):972–981
Ercole F, Mansfeld FM, Kavallaris M, Whittaker MR, Quinn JF, Halls ML, Davis TP (2017) Macromolecular hydrogen sulfide donors trigger spatiotemporally confined changes in cell signaling. Biomacromolecules 17(1):371–383
Frantzias J, Logan JG, Mollat P, Sparatore A, Soldato PD, Ralston SH, Idris AI (2012) Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo. Br J Pharmacol 165(6):1914–1925
Hammers MD, Singh L, Montoya LA, Moghaddam AD, Pluth MD (2016) Synthesis of amino-ADT provides access to hydrolytically stable amide-coupled hydrogen sulfide releasing drug targets. Synlett 27(9):1349–1353
Huang JY, Yang LD, Su CH, Chu XW, Zhang JY, Deng SP, Cheng KG (2018) Synthesis and cytotoxicity evaluation of pentacyclic triterpene–phenol nitrogen mustard conjugates. Chem Nat Comp 54(1):106–111
Huang LR, Luo H, Yang XS, Chen L, Zhang JX, Wang DP, Hao XJ (2014) Enhancement of anti-bacterial and anti-tumor activities of pentacyclic triterpenes by introducing exocyclic α,β-unsaturated ketone moiety in ring A. Med Chem Res 23(11):4631–4641
Imbrogno S, Filice M, Cerra MC, Gattuso A (2018) NO, CO, and H2S: what about gasotransmitters in fish and amphibian hearts? Acta Physiologica 223(1):e13035
Jia J, Xiao Y, Wang W, Qing L, Xu Y, Song H, Zhen X, Ao G, Alksasyed N, Cheng J (2013) Differential mechanisms underlying neuroprotection of hydrogen sulfide donors against oxidative stress. Neurochem Int 62(8):1072–1078
Kaium MA, Yan L, Zhu Q, Liu C, Duan JL, Tan BK, Yi ZZ (2011) H2S donor, S-propargyl-cysteine, increases CSE in SGC-7901 andcancer-induced mice: evidence for a novel anti-cancer effect of endogenous H2S? PLoS ONE 6(6):e20525
Kandefer-Szerszen M, Paduch R (2014) Antitumor and antiviral activity of pentacyclic triterpenes. Mini-Rev Org Chem 11(3):262–268
Kodela R, Chattopadhyay M, Kashfi K (2012) NOSH-Aspirin: a novel nitric oxide–hydrogen sulfide-releasing hybrid: a new class of anti-inflammatory pharmaceuticals. ACS Med Chem Lett 3(3):257–262
Lee ZW, Zhou J, Chen CS, Zhao Y, Tan CH, Li L, Moore PK, Deng LW (2011) The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo. PLoS ONE 6(6):e21077
Luzina OA, Salakhutdinov NF (2018) Usnic acid and its derivatives for pharmaceutical use: a patent review (2000–2017). Expert Opin Ther Pat 28(6):477–491
Mallavadhani UV, Mahapatra A, Pattnaik B, Vanga N, Suri N, Saxena AK (2013) Synthesis and anti-cancer activity of some novel C-17 analogs of ursolic and oleanolic acids. Med Chem Res 22(3):1263–1269
Olas B (2015) Hydrogen sulfide in signaling pathways. Clin Chim Acta 439:212–218
Olson KR, Healy MJ, Qin Z, Skovgaard N, Vulesevic B, Duff DW, Whitfield NL, Yang GD, Wang R, Perry SF (2013) Hydrogen sulfide as an oxygen sensor in trout gill chemoreceptors. Am J Physiol-Regulatory, Integr Comparative Physiol 295(2):669–680
Powell CR, Dillon KM, Matson JB (2017) A review of hydrogen sulfide (H2S) donors: chemistry and potential therapeutic applications. Biochem Pharmacol 149:110–123
Ryazantseva NV, Novitsky VV, Starikova EG, Kleptsova LA, Jakushina VD, Kaigorodova EV (2011) Role of hydrogen sulfide in the regulation of cell apoptosis. Bull Exp Biol Med 151(6):702–704
Shen J, Xu X, Cheng F, Liu H, Luo X, Shen J, Chen K, Zhao W, Shen X, Jiang H (2003) Virtual screening on natural products for discovering active compounds and target information. Curr Med Chem 10(21):2327–2342
Shen L, Lai Y, Zhang Y, Luo X, Yuan S (2008) Synthesis and anti-tumor activities of nitrate derivatives of glycyrrhetinic acid. J China Pharm Univ 39(2):103–107
Shyu MH, Kao TC, Yen GC (2010) Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP. J Agr Food Chem 58(10):6110–6118
Tsai SJ, Yin MC (2010) Antioxidative and anti-inflammatory protection of oleanolic acid and ursolic acid in PC12 cells. J Food Sci 73(7):174–178
Van Meerloo J, Kaspers GJ, Cloos J (2011) Cell sensitivity assays: the MTT assay. Methods Mol Biol 731:237–245
Yang YF, Yang LY, Han YD, Wu ZW, Chen P, Zhang HB, Zhou JP (2017) Protective effects of hepatocyte-specific glycyrrhetic derivatives against carbon tetrachloride-induced liver damage in mice. Bioorg Chem 72:42–50
Acknowledgements
This study was financially supported by grants from the National Natural Science Foundation of PRC (21562006), Guangxi Natural Science Foundation of China (2015GXNSFAA139186), Guangxi′s Medicine Talented Persons Small Highland Foundation (1506), Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University), and Ministry of Education of China (CMEMR2013-A01, CMEMR2013-C02), and IRT_16R15.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
About this article
Cite this article
Sheng, Lx., Huang, Jy., Liu, Cm. et al. Synthesis of oleanolic acid/ursolic acid/glycyrrhetinic acid-hydrogen sulfide donor hybrids and their antitumor activity. Med Chem Res 28, 1212–1222 (2019). https://doi.org/10.1007/s00044-019-02366-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-019-02366-w